Poseida Therapeutics Inc (PSTX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -196.826 | -90.078 | -50.06 | -39.006 | -20.608 | -39.452 |
| Return on Equity (%) | 115.759 | 76.495 | -230.799 | -59.771 | -37.231 | -84.745 |
| Return on Invested Capital (%) | -737.836 | -160.32 | -66.105 | -59.997 | -28.22 | -63.875 |
| Operating Margin (%) | N/A | N/A | N/A | -389.321 | -43.748 | -177.197 |
| Net Profit Margin (%) | N/A | N/A | N/A | -400.07 | -49.047 | -190.764 |
| Book Value Per Share | -0.641 | 4.078 | 4.145 | 2.41 | 2.118 | 1.026 |
| Earnings Per Share | -2.901 | -5.258 | -2.098 | -1.999 | -0.745 | -1.291 |
| Cash Per Share | 1.986 | 5.334 | 1.357 | 3.3 | 0.947 | 0.465 |
| Working Capital Per Share | 1.281 | 6.4 | 4.59 | 2.728 | 2.846 | 1.623 |
| Operating Profit Per Share | N/A | N/A | N/A | 0.5 | 1.518 | 0.677 |
| EBIT Per Share | -2.914 | -5.258 | -2.098 | -1.999 | -0.738 | -1.29 |
| EBITDA Per Share | -2.914 | -5.258 | -2.098 | -1.999 | -0.738 | -1.29 |
| Free Cash Flow Per Share | -2.862 | -5.017 | -1.866 | -2.029 | -0.759 | -1.317 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | 2.506 | 5.819 | 10.458 | 4.935 | 5.541 | 3.176 |
| Quick Ratio | 2.334 | 5.734 | 10.296 | 4.761 | 5.411 | 3.102 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 15.31M | 16.46M | 61.86M | 62.52M | 85.96M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 62.73M | 85.95M | 85.96M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | -355.98 | N/A | N/A | N/A | -78.25 |
| Net Profit Margin (%) | N/A | N/A | N/A | -375.587 | N/A | N/A | N/A | -86.255 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 5.354 | N/A | N/A | N/A | 2.557 |
| Quick Ratio | N/A | N/A | N/A | 5.25 | N/A | N/A | N/A | 2.485 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 313.17M |
| Price to Earnings Ratio | -2.62 |
| Price to Sales Ratio | 4.99 |
| Price to Cash Ratio | 7.26 |
| Price to Book Ratio | 3.11 |
| Dividend Yield | - |
| Shares Outstanding | 96.96M |
| Average Volume (1 week) | 406.35k |
| Average Volume (1 Month) | 389.61k |
| 52 Week Change | 69.54% |
| 52 Week High | 4.27 |
| 52 Week Low | 1.60 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
